The Automated Breast Volume Scanner (ABVS): initial experiences in lesion detection compared with conventional handheld B-mode ultrasound: a pilot study of 50 cases by Wojcinski, Sebastian et al.
© 2011 Wojcinski et al, publisher and licensee Dove Medical Press Ltd.   This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Women’s Health 2011:3 337–346
International Journal of Women’s Health Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
337
OrIgInAL reseArcH
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/IJWH.S23918
The Automated Breast Volume scanner (ABVs): 
initial experiences in lesion detection compared 
with conventional handheld B-mode ultrasound:  
a pilot study of 50 cases
sebastian Wojcinski1
Andre Farrokh1
Ursula Hille2
Jakub Wiskirchen3
samuel gyapong1
Amr A soliman1,4
Friedrich Degenhardt1
Peter Hillemanns2
1Department of OB/gYn, Franziskus 
Hospital, Bielefeld, germany; 2Department 
of OB/gYn, Hannover Medical school, 
Hannover, germany; 3Department of 
radiology, Franziskus Hospital, Bielefeld, 
germany; 4Department of OB/gYn, Faculty 
of Medicine, University of Alexandria, 
Alexandria, egypt
correspondence: sebastian Wojcinski 
Franziskus Hospital, Department  
of OB/gYn, Kisker str 27, 33615  
Bielefeld, germany 
Tel +49 521 589 1501 
Fax +49 521 589 1504 
email s@wojcinski.de
Abstract: The idea of an automated whole breast ultrasound was developed three decades ago. 
We present our initial experiences with the latest technical advance in this technique, the automated 
breast volume scanner (ABVS) ACUSON S2000TM. Volume data sets were collected from 50 
patients and a database containing 23 women with no detectable lesions in conventional ultrasound 
(BI-RADS®-US 1), 13 women with clearly benign lesions (BI-RADS®-US 2), and 14 women with 
known breast cancer (BI-RADS®-US 5) was created. An independent examiner evaluated the ABVS 
data on a separate workstation without any prior knowledge of the patients’ histories. The diagnostic 
accuracy for the experimental ABVS was 66.0% (95% confidence interval [CI]: 52.9–79.1). The 
independent examiner detected all breast cancers in the volume data resulting in a calculated sensi-
tivity of 100% in the described setting (95% CI: 73.2%–100%). After the ABVS examination, there 
were a high number of requests for second-look ultrasounds in 47% (95% CI: 30.9–63.5) of the 
healthy women (with either a clearly benign lesion or no breast lesions at all in conventional handheld 
ultrasound). Therefore, the specificity remained at 52.8% (95% CI: 35.7–69.2). When comparing 
the concordance of the ABVS with the gold standard (conventional handheld ultrasound), Cohen’s 
Kappa value as an estimation of the inter-rater reliability was κ = 0.37, indicating fair agreement. 
In conclusion, the ABVS must still be regarded as an experimental technique for breast ultrasound, 
which definitely needs to undergo further evaluation studies.
Keywords: breast cancer, automated breast ultrasound, automated breast volume scanner, 
ABVS
Introduction
Breast ultrasound is a commonly accepted and reliable diagnostic method for women 
with clinically or radiologically suspicious breast lesions.1 Although it is not estab-
lished as a routine part of screening programs, bilateral whole breast ultrasound has 
even demonstrated diagnostic advantages in screening asymptomatic women.2–6 Breast 
ultrasound has been performed for more than 50 years.7,8 Conventional handheld 
ultrasound (HHUS) is the gold standard for performing the examination. Obviously, 
sonography is an examiner-dependent method and the examiner has to be present at 
the time of image acquisition.
The concept of automated breast ultrasound dates back to the 1970s when the first 
applicable systems were reported by Maturo et al.9 In the current report we present our 
initial experiences with the latest technical advance in automated breast ultrasound, 
the Automated Breast Volume Scanner (ACUSON S2000TM ABVS; Siemens Medical 
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Solutions, Inc, Mountain View, CA). This system can be 
operated by an assistant medical technician or radiographer. 
The ABVS acquires a whole series of consecutive B-mode 
pictures and reconstructs 3D data sets of the entire breast 
volume. These data can be sent to a separate workstation to 
be independently analyzed by a specialist.
We evaluated whether or not breast lesions, previously 
detected by means of conventional ultrasound, could also be 
detected and correctly classified by an independent examiner 
who used only ABVS data. To the best of our knowledge, this 
is one of the first descriptive studies dealing with the clinical 
application of the ABVS system.
Materials and methods
general design and creation  
of the patient database
Our study was conducted at the Breast Cancer Center of 
Franziskus Hospital in Bielefeld, Germany, between March 
2010 and May 2010. The responsible ethical committee did 
not require additional approval for this noninterventional 
study design. All examinations were performed using the 
Siemens ACUSON S2000TM ultrasound system (Siemens 
Medical Solutions, Inc, Mountain View, CA).
The study cohort was recruited from patients who 
attended the outpatient service of our breast cancer center. 
The patients were referred to our clinic due to specific diag-
nostic queries such as palpable breast lesions, breast pain, 
suspicious mammograms, and intensified screening in high-
risk populations. All patients received conventional HHUS as 
the standard diagnostic method and subsequent examinations 
whenever necessary. For each patient, the B-mode ultrasound 
pictures were categorized according to the Breast Imaging 
Reporting and Data System criteria of the American College 
of Radiology (ACR BI-RADS®-US).10
Patients with a final categorization of BI-RADS®-US 1, 
2, and 5 in the conventional ultrasound examination were 
regarded as being suitable for our study. We excluded patients 
with BI-RADS®-US 0, 3 and 4 lesions as the focus of our 
study was on the bare detection of clearly benign and clearly 
malignant lesions and not on the evaluation of questionable 
lesions.
Patients with a history of breast surgery, bra cup sizes 
greater than D, inflammatory conditions of the breast, and 
skin disorders were also excluded.
Patients who met the inclusion criteria and who agreed 
to be enrolled in our study signed an informed consent 
form and subsequently received the additional ABVS 
examination.
Thus, we created a database containing 50 patients exhib-
iting BI-RADS®-US 1, 2, and 5 findings in conventional 
examinations. In our cohort the age ranged from 32 to 72 
years (median 52 years). According to the BI-RADS®-US 
categorization, 46% (n = 23) of our cases were assigned as 
BI-RADS®-US 1, 26% (n = 13) had BI-RADS®-US 2 lesions, 
and 28% (n = 14) of the cases had BI-RADS®-US 5 lesions. 
All cases of BI-RADS®-US 5 were histologically confirmed 
after the study setting was completed.
The mean tumor size for the malignant lesions was 
23.4 mm (range 13 to 55).
After anonymization, the ABVS database was then 
available for evaluation by an independent second examiner. 
We compared the performance of the ABVS (experimental 
method) to the HHUS (gold standard).
Technical background of the ABVs
The ACUSON S2000TM ABVS is an ultrasound system that 
automatically surveys and acquires full-field volumes of the 
breast (Figure 1).
For automated scanning, we used the integrated Siemens 
14L5BV linear transducer (14 MHz, 15.4 cm) with 768 
piezoelectric elements. These images have a depth of up to 
6 cm. In the process of automated scanning, the transducer 
covers a distance of 16.8 cm, acquiring 318 high-resolution 
slices for post-processing. Therefore, the maximum volume 
is 1552.3 cm³ and the slice thickness is about 0.5 mm.
In order to optimize the ABVS results there is a wide range 
of known imaging modes including tissue harmonic imaging 
(THI) and Advanced SieClearTM spatial compounding and 
Dynamic TCETM (tissue contrast enhancement) technology, 
Figure 1 Installation of the AcUsOn s2000TM ABVs ultrasound system. On the 
left-hand  side  is  the  AcUsOn  s2000TM  machine,  on  the  right-hand  side  is  the 
14L5BV volume transducer attached to a mechanical arm.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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as well as new processing algorithms for nipple shadow and 
reverberation artifacts that are automatically applied when 
using the ABVS. The Reverberation Removal Algorithm 
processes the 3D data and determines whether tissue contact 
is present and where it is not. The data corresponding to the 
area with no tissue contact are removed. This is intended to 
suppress the reverberation artifacts from the noncontact areas. 
The adaptive Nipple Shadow Reduction Tool analyzes data on 
a case-by-case basis and is thought to enhance the structures 
in the retro-areolar area and to improve the visualization of 
this important region. Finally, a Gain Collection Algorithm 
analyzes the 3D data and adjusts for the brightness variation 
artifacts caused by transducer channel-to-channel variations.
After acquisition, the data are automatically sent from the 
ultrasound system to a breast ultrasound review workstation, 
which provides comprehensive analysis and manipulation of 
the 3D data: the workstation presents images through multi-
planar reconstruction (MPR, Figure 2). All volume data sets 
can also be viewed in multiple orientations, including the 
standard transverse, sagittal, coronal, radial, and anti-radial 
planes, as well as any other user-defined plane (Figure 3). 
Secondary images are reconstructed from the acquisition 
volume in any plane in real-time (Figure 4). A standardized 
scanning technique, which was also used in our study, has been 
described elsewhere.11
Standard HHUS examination (definition 
of the gold standard)
Clinical history taking and clinical examination, and the 
HHUS, were performed by the author SW, a DEGUM 
(Deutsche Gesellschaft für Ultraschall in der Medizin, 
  German society for ultrasound in medicine) level II certified 
senior consultant in gynecology with 7 years’ experience in 
breast ultrasound.12 This examiner also knew the results of 
the other imaging modalities when available (mammography, 
magnetic resonance imaging [MRI]).
For HHUS we used the integrated Siemens 18L6 HD 
linear transducer (5.5–18 MHz, 5.6 cm). The patient was 
in the supine position with the ipsilateral hand raised 
above the head. All examinations were performed with 
the ultrasound probe oriented perpendicular to the chest 
wall. During each examination, all necessary B-mode 
pictures were first obtained according to the diagnostic 
standards. All images were digitally recorded. The exam-
iner categorized the breast lesions detected according to 
the ACR BI-RADS®-US classification system. These results 
were defined as the gold standard (reference standard) for 
comparison with the experimental method. All standard 
examinations were completed before the patients were 
enrolled in the study. Eligible patients were subsequently 
examined using the ABVS.
Figure 2 Multi-planar reconstruction of the volume data displayed on the automated 
breast volume scanner workplace.
Figure 3 coronal view of the volume data at a depth of 10.4 mm from the skin line. 
The yellow spot indicates the position of the nipple.
Figure 4 This view provides the coronal (left), transverse (upper right) and sagittal 
(lower right) planes. The body marker indicates that this volume was acquired at 
the apex of the left breast. The yellow spot marks the position of the nipple. A 
point of interest can be chosen and marked by two orthogonal lines. Then, the 
corresponding cross-sections are calculated in real-time and shown in the other 
planes. The images can be optimized by adjusting the magnification, brightness, and 
contrast.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Acquisition of the ABVs data
The experimental ABVS examination was also performed 
by the author, SW. For the ABVS examination, the patient 
was placed in the same position as for the HHUS. A special 
ultrasound lotion that provides optimal imaging results in 
combination with the ABVS was applied to the skin instead 
of the usual ultrasound gel (Polysonic Ultrasound Lotion, 
Parker Laboratories, Inc, Fairfield, NJ).
According to other studies, we used the bra cup size to 
describe the size of the breast.13 Bra cup size is determined 
by measuring the horizontal chest circumference in the infra-
mammary fold, adding 5 inches (12.7 cm) and subtracting 
the horizontal chest circumference at the fullest part of the 
breasts. A difference of 1 inch (2.54 cm) is equivalent to an 
A cup, 2 inches a B cup, and so on.14 We did not perform 
this measurement in the current study, but instead asked the 
patients for their bra cup size.
Depending on the bra cup size, the examiner chose the 
number of scans to be taken from each side. Usually, breasts 
with A-cup and B-cup sizes can be fully displayed by per-
forming two volume scans (medial and lateral, Figure 5). 
In breasts with C-cup or D-cup sizes it is often necessary 
to choose additional views (usually a separate view of the 
apex and the axillary process of the breast, Figure 5).
As standard, there is a replaceable membrane fixed to 
the transducer to assure sufficient contact with the skin of 
the entire area. In order to acquire the ultrasound image 
volume, the 14L5BV transducer was positioned on the 
breast with slight pressure. The mechanical arm that is 
part of the scanner column was locked in the chosen posi-
tion. A preset scanning program was chosen according to 
the bra cup size of the breast. In addition, all previously 
known ultrasound features were available in order to opti-
mize picture   quality. The automated scan took between 
55 and 65 seconds. There was no need for breath holding 
during this time. After a particular scan was completed, 
the coronal plane of the   volume acquired was displayed at 
the height of skin level. This enabled the examiner to set 
a fixed marker on the nipple, allowing orientation in the 
subsequent analysis. Finally, the entire set of volume scans 
was sent to the workstation.
Independent interpretation of the 
experimental ABVs data (by examiner 2)
The independent interpretation of the ABVS data sets was 
performed by the co-author AF, a DEGUM level I certified 
senior resident in gynecology with 4 years’ experience in 
breast ultrasound.
The second examiner exclusively analyzed the 3D data 
sets without prior knowledge of the patients’ histories, clini-
cal findings, or results of the other imaging modalities. The 
second examiner had no information about the proportion 
of BI-RADS®-US 1, 2, and 5 cases in the database, but 
he did know that BI-RADS®-US 3 and 4 cases had been 
excluded.
This examiner was able to use a variety of tools for image 
manipulation, including the standard views (axial, sagittal, 
coronal, radial, anti-radial), user-defined views, rotation 
around x, y, z axes, free rotation around any point of interest, 
a magnifier and interactive zoom, marking and annotation of 
areas of interest, and the generation of snapshots.
The second examiner used the following standard proce-
dure to analyze the ABVS data sets: first, the whole volume 
was analyzed in the coronal plane moving slowly from the 
skin to the chest wall. Suspicious lesions were marked with 
the system’s default tool. In the next step, all lesions were 
evaluated by generally re-examining them in the sagittal 
and axial planes (and optionally in any other plane), using 
adequate magnification, brightness, and   contrast. Finally, 
the examiner moved through the whole volume in the sagit-
tal and axial planes in order to   potentially detect additional 
lesions that were not seen in the coronal plane. Lastly, the 
examiner assigned the lesions a category according to the 
ACR BI-RADS®-US system.
Despite the fact that the second examiner knew that there 
were no BI-RADS®-US 0, 3, or 4 cases in the database, he 
was allowed to categorize lesions as BI-RADS®-US 0, 3, or 
4 whenever he requested a second-look ultrasound in order 
to scrutinize suspicious lesions.
When a second-look ultrasound was requested for a lesion 
that eventually turned out to be benign, the result of the AVBS 
examination was defined as “nonconcordant” and “false-
positive”. On the other hand, when a second-look ultrasound 
was requested for a lesion that turned out to be malignant, 
the result was classified as “true-positive” because the cancer 
could then be correctly detected in the subsequent conventional 
ultrasound.
Figure 5 Predefined positions of the scanner, which are used to cover the entire 
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Ultrasound quality assurance
Due to the national regulating authority statutes, all breast 
ultrasound systems have to fulfill basic technical requirements 
and undergo regular quality control measures.15 The technical 
requirements include a linear transducer   covering a least 
38 mm, an ultrasound frequency $7 MHz, an adjustable 
digital focus, a time gain control signal generator, a frame rate 
$15 fps, an image depth $6 cm, the detection of a returning 
echo $ 60 dB below the transmitted signal, and at least 8-bit 
processing of the images.
In order to guarantee long-lasting performance of the 
transducer and conformance of the whole device with the 
standards, a compliance test is mandatory when setting up a 
new ultrasound system and a consistency inspection is needed 
every 4 years. All of the abovementioned standards applied 
to the equipment used in our study.
statistical analysis
The software package SPSS Statistics (v 17.0; SPSS, Inc, 
Chicago, IL) was used for the statistical analysis. The results 
obtained from the experimental method (ABVS) were com-
pared with the results from the gold standard (HHUS). The 
data were analyzed using descriptive statistics. The diagnostic 
sensitivity and specificity, as well as the accuracy of the ABVS, 
were calculated based on the Bayesian theorem using Fisher’s 
exact test.
The Chi-square test was used to assess the correlation 
between the expected and the observed rate of second-look 
ultrasounds.
Calculation of the concordance with the BI-RADS® 
  classification was based on Cohen’s Kappa test.16 Although 
both examiners (for both HHUS and ABVS) had differ-
ent degrees of information about the patients, this test can 
provide a satisfactory estimation of the true inter-rater 
reliability. We used the magnitude guidelines published by 
Landis and Koch, who characterized the values of κ , 0 as 
indicating no agreement and κ 0–0.20 slight, κ 0.21–0.40 
fair, κ 0.41–0.60 moderate, κ 0.61–0.80 substantial, and κ 
0.81–1 as almost perfect agreement.17
Statistical significance was assumed at P , 0.05 for all 
tests.
Results
Accuracy, sensitivity, and specificity  
of the ABVs
The sensitivity of the ABVS in detecting malignant lesions 
ranged from 73.2 to 100% (95% CI), and all of the 14 
cancer patients were detected by the second examiner. 
The diagnostic accuracy of the experimental ABVS was 
66.0% (95% CI: 52.9–79.1). The specificity seemed to 
be quite low at 52.8% (95% CI: 35.7–69.2) as there was 
a high number of requests for second-look ultrasounds 
after the ABVS and these cases are, as a matter of fact, 
false-positive if there is no cancer. These results must be 
carefully interpreted, bearing in mind that the experimental 
ABVS was performed on a subset of patients with results 
defined by the HHUS.
rate of second-look ultrasounds
We expected 14 (28%) requests for second-look ultrasound 
after the ABVS examination as there were 14 cases of 
BI-RADS®-US 5 lesions. We did not expect requests for 
the other 36 cases (BI-RADS®-US 1 or 2 lesions). Nev-
ertheless, the observed rate of second-look ultrasounds 
was significantly high, totaling 62% (95% CI: 48.6–75.5, 
P , 10−8).
Regarding the subgroups, there was a request for a 
second-look ultrasound in 61.5% (95% CI: 35.1–88.0) of 
the women with benign lesions and even in 39.1% (95% 
CI: 19.2–59.1) of the women with no breast lesions at all. 
Overall, examiner 2 requested second-look ultrasounds 
for all 14 cases of breast cancer but also in 17 of the 36 
controls (47% [95% CI: 30.9–63.5]). These data are shown 
in Table 1.
Table 1 Agreement between examiner 1 (gold standard) and examiner 2 (experimental ABVs data interpretation) focusing on the 
correct clinical decision of whether the patient should undergo a control ultrasound due to a suspicious finding or whether the patient 
should be defined as healthy as there is no suspicious lesion
Classification by examiner 1using all information  and HHUS  
(gold standard)
Total
Disease - (BI-RADS 1, 2) Disease + (BI-RADS 5)
Classification by examiner 2 analyzing the ABVS data (experimental method)
ABVs − (BI-rADs 1, 2) 19 0 19
ABVs + (BI-rADs 0, 3, 4, 5) 17 14 31
Total 36 14 50
Abbreviations: ABVs, automated breast volume scanner; HHUs, handheld ultrasound.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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estimation of the inter-rater reliability
We compared the results of the BI-RADS®-US classification by 
the second examiner, who only had access to the ABVS data but 
not to any other information, with the results of the first examiner 
(HHUS, which can be seen as the gold standard). Cohen’s Kappa 
value as an estimation of the inter-rater   reliability regarding this 
comparison was κ = 0.37 (95% CI: 0.19–0.55), reaching an 
agreement that can be described as fair between both modalities. 
The detailed results are shown in Table 2.
Diagnostic performance in the subgroup 
of BI-rADs®-Us 5 lesions
Focusing on the 14 lesions that were classified as BI-RADS®-US 
5 in conventional ultrasound, we obtained the following 
results: eight out of 14 lesions (57%) were correctly classified 
as BI-RADS®-US 5, and six out of 14 lesions were classi-
fied as BI-RADS®-US 0, 3 or 4, resulting in a second-look 
ultrasound being requested by examiner 2. Therefore, none of 
the carcinomas would have been missed by the ABVS, as all 
patients were scheduled for further examinations and none of 
the 14 patients was classified as BI-RADS®-US 1 or 2, which 
would have resulted in a delayed diagnosis.
Diagnostic performance in the subgroup 
of BI-rADs®-Us 2 lesions
With respect to the BI-RADS®-US 2 lesions (n = 13), we 
performed a test identical to the BI-RADS®-US 5 lesion test. 
Only four (30.8%) of these lesions were correctly classified as 
BI-RADS®-US 2. One lesion was missed and the breast was 
therefore classified BI-RADS®-US 1. A second-look ultrasound 
was requested in eight cases (61.5% [95% CI: 35.1–88.0]) as 
examiner 2 either diagnosed a questionable lesion (six cases) 
or was suspicious of a malignant lesion (2 cases).
Diagnostic performance in the subgroup 
of BI-rADs®-Us 1 breasts
Furthermore, we analyzed the dataset of BI-RADS®-US 1 
breasts, which exhibited no verifiable lesions (n = 23); 13 
(56.5%) were correctly described as BI-RADS®-US 1. In one 
case, examiner 2 suspected a benign lesion (BI-RADS®-US 
2, Figure 6). There were no category BI-RADS®-US 5 
diagnoses, but nine (39.1% [95% CI: 19.2–59.1]) second-
look ultrasounds were requested due to questionable lesions 
categorized as BI-RADS®-US 0, 3 or 4.
experiences in clinical applicability
The standard examinations, which included history taking, 
clinical examination, and HHUS, took about 20–30 minutes 
on average per patient. An additional 8–10 minutes was 
needed to acquire the ABVS data sets. This extra time period 
included informing the patient about the procedure, applying 
the ultrasound lotion, and acquiring two to four image sets 
per breast. Regarding the size of the breast, there was no 
difficulty in acquiring the whole breast volume in women 
with bra cup sizes A to D, but there were noticeable deficits 
in women with larger breasts. Interpretation times were about 
6–10 minutes per patient. However, excessive time had to be 
spent on the second-look HHUS, as mentioned above.
clinical examples
Figure 7 shows a case from the database that was correctly clas-
sified as BI-RADS®-US 5 (Figure 7). The 53-year-old patient 
was asymptomatic and had had a screening mammogram 
6 months earlier with no evidence of a malignant breast lesion. 
The breast density had been categorized as ACR III. The patient 
reported menopause one year earlier. She had given birth to 
three children (first child at the age of 20 years), but there was 
no history of breast feeding. Her body mass index was 21.4 at 
the time of presentation and her bra cup size was B. The patient 
reported no hormone replacement therapy and no other relevant 
intake of medications. There was no family history of cancer. 
The patient was sent to our breast cancer center because of a 
suspicious finding in a conventional breast ultrasound that had 
been performed for screening purposes. The lesion remained 
occult in the directly repeated mammogram. The occult lesion 
could also be easily detected by the ABVS system.
Table 2 Agreement between examiner 1 (gold standard) and examiner 2 (experimental ABVs data interpretation) focusing on the 
correct classification according to the ACR BI-RADS®-Us system
Classification by examiner 1 using all information and HHUS (reference standard) Total
BI-RADS 1 BI-RADS 2 BI-RADS 0, 3, 4 (excluded) BI-RADS 5
Classification by examiner 2 analyzing the ABVS data (experimental method)
BI-rADs 1 13 1 0 0 14
BI-rADs 2 1 4 0 0 5
BI-rADs 0, 3, 4 9 6 0 6 21
BI-rADs 5 0 2 0 8 10
Total 23 13 0 14 50
Abbreviations: ABVs, automated breast volume scanner; HHUs, handheld ultrasound.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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four invasive lesions in order to get an idea of the required resec-
tion volume. Finally, we performed a quadrantectomy after 
wire localization of the superior and inferior limits of the area. 
The histological results revealed clear resection margins for all 
four lesions. Due to the 3-dimensional planning of the surgical 
procedure, an acceptable cosmetic result was achieved.
Figure 9 shows the case of a 47-year-old patient with 
a locally advanced invasive lobular carcinoma of the right 
breast. The dimension of the lesion was poorly seen in the 
mammogram and the lesion was too extensive for distinct 
measurement or localization in the conventional ultrasound. 
Therefore, we ordered an MRI as well as an ABVS examina-
tion. In the coronal plane derived from the ABVS 3D data set, 
we were able to detect the lesion easily, with its associated 
tissue distortion and spiculations, enabling us precisely to 
perform a tumor-adapted reduction mammaplasty. An excel-
lent correlation was found between the suspected dimensions 
of the lesion in the MRI and the ABVS compared with the 
histological results.
Figure 6 case from the database demonstrating a BI-rADs®-Us 1 breast that 
was interpreted as a BI-rADs®-Us 2 lesion, mainly visible in the coronal plane by 
examiner 2.
Figure 7 case from the database demonstrating a BI-rADs®-Us 5 lesion that 
remained occult in the mammogram. The lesion was easily detected in the volume 
data set by examiner 2 (A) and a second-look ultrasound (B) with histological 
confirmation was correctly requested.
We would like to present three further clinical examples 
that were not included in our database but which illustrate the 
diagnostic imaging capabilities of the automated ultrasound 
system. Although there is no superiority of the ABVS over 
HHUS in these cases, there might be hints for the future 
implementations of the ABVS as a useful method in breast 
diagnostics.
Figure 8 shows a 50-year-old patient with known multifocal 
breast cancer. We used the ABVS system to exactly locate the 
Figure 8 clinical example of multifocal breast cancer. With conventional ultrasound, 
even when using techniques such as siescape® panoramic imaging, it is difficult to 
display more than three lesions at the same time (A). In the coronal plane, derived 
from the volume data sets, all foci can be viewed at the same time (B). While 
remaining aware of the extension of tissue changes, we planned a quadrantectomy 
after wire localization.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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Finally, we present the case of a 53-year-old patient who 
presented to us with bloody nipple discharge   (Figure 10). 
Before any manipulation of the breast by a clinical examina-
tion, galactography, or conventional ultrasound, we performed 
an ABVS examination. A pathological duct ectasia at the 9 
o’clock position was clearly displayed in the coronal plane. 
Upon reconstructing the other planes we suspected an intra-
ductal proliferation. Galactography was performed that con-
firmed the diagnosis of intraductal proliferation. Cytological 
examination of the discharge yielded no additional informa-
tion. Therefore, a ductectomy was performed and the final 
histological diagnosis was a benign intraductal papilloma.
Discussion
Breast ultrasound, as currently considered among breast 
imaging modalities, has an essential and specific role as a 
complementary method to mammography, by adding to the 
diagnostic accuracy. Breast ultrasound is an accepted and 
well-established diagnostic tool for women with clinically or 
radiologically detected suspicious breast lesions.1 Handheld 
ultrasound represents the gold standard for this examination.
Figure 9 clinical example of an invasive lobular breast cancer. In order to estimate 
the extension of the lesion, we performed both MrI and the automated breast 
volume scanner. The coronal planes of both imaging modalities demonstrated a 
correlation in the measurements of the lesion.
Figure 10 clinical example of a patient with nipple discharge. The duct ectasia can 
be seen in the reconstructed coronal plane (A, left), and an intraductal lesion was 
suspected in the transverse (A, upper right) and sagittal planes (A, lower right). 
conventional ultrasound (B) confirmed the diagnostic findings of a vasculated (C) 
papillary lesion.International Journal of Women’s Health 2011:3 submit your manuscript | www.dovepress.com
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The concept of breast cancer diagnosis using an automated 
ultrasound system must be regarded as an experimental 
approach. Nevertheless, the general idea is not new and 
the technical equipment has evolved over the last three 
decades.18–20 However, automated whole breast scanning is 
far from representing an accepted medical practice and its 
application still lacks solid data from prospective studies.
We present our initial experiences with the latest genera-
tion of an automated breast ultrasound system, the Automated 
Breast Volume Scanner ACUSON S2000TM ABVS (Siemens 
Medical Solutions, Inc, Mountain View, CA).
In a clinical setting, use of the ABVS is a feasible method 
that can be easily integrated into the workflow of a breast 
cancer center. As the probe is equipped with 768 piezoelectric 
elements and reaches 14 MHz, we found sufficient image 
quality and resolution. The ABVS guarantees high patient 
safety as there is no exposure to ionizing radiation and no 
injection of contrast medium.
The ABVS image data provide the following additional 
information to the examiner: the coronal view of the entire 
volume offers an easily understandable representation of the 
breast’s global anatomy and architecture. In particular, the 
segmental organization of the ductal system and surrounding 
tissue is clearly visualized. This view provides physicians 
and, especially, surgeons a comprehensive sight of the breast 
from the skin line to the chest wall. In our experience this 
information helps in better defining the margins for resection 
in breast cancer surgery.
The HHUS is known to be a time-consuming, examiner-
dependent, and therefore expensive procedure. At first 
glance, the ABVS seems to overcome these problems as it 
can be performed by a medical assistant, it allows a delayed 
interpretation of the images by an independent examiner at 
any time, and it provides reproducible, standardized views 
of the entire breast volume. Indeed, the examination time 
can initially be reduced from approximately 20–30 minutes 
for a full HHUS to 8–10 minutes with the ABVS. On the 
other hand, the large number of time-consuming second-look 
ultrasounds has to be taken into account. In fact, these exami-
nations are performed by conventional HHUS and therefore 
dissolve any previously assumed advantages regarding time. 
However, our study was not designed to fully answer the 
question of examination time.
The reason for the high rate of second-look ultrasounds 
can be explained by the fact that when the ABVS system is 
used, we lose the ability to immediately explore further a 
questionable lesion by modifying factors such as compres-
sion, the orientation of the probe, and the machine’s setting 
while acquiring the image in real-time. Ultrasound techniques 
such as Doppler imaging or sonoelastography cannot be used 
either. Furthermore, we lack standardized interpretation 
criteria and there are still technical artifacts in the volume 
data set. These problems are reflected in the low specificity 
of 52.8%. Nevertheless, with accumulating data, growing 
experience, standardized diagnostic criteria, and optimized 
techniques, this specificity might be improved.
In our preselected database we apparently showed a high 
sensitivity to the method (nominally 100% [95% CI: 73.2–
100]), as no case of breast cancer was missed or misinterpreted 
as a benign lesion. These results must definitely undergo further 
confirmation as there were several limitations to our study.
The main limitation to our study was the design with 
a limited sample size of only 50 preselected patients. The 
proportion of cases to controls was not representative of the 
whole population. Therefore, the results concerning sensi-
tivity, specificity, and the rate of second-look ultrasounds 
cannot be applied to the general population and hence must 
be carefully interpreted. We present our work only as a pilot 
study with a completely new ultrasound system.
With a more representative cohort and with even more 
experience in interpreting the volume data sets, we would 
expect to find a lower number of requests for second-look 
ultrasounds and improved specificity, but also a lower sen-
sitivity. Other limitations included the small sample size, 
resulting in vast confidence intervals, and the unicentric 
nature of the study. As previously mentioned, the technique 
itself is limited to women with breast sizes up to a bra cup-
size D. In addition, there is no experience in examining the 
axillary region with the ABVS, although this region is of 
special importance in breast cancer diagnostics.
In order to move this technique forward, there is a definite 
need for further research. In particular, we require prospective 
studies recruiting larger patient cohorts. This would involve 
a multi-center design and could also include a multi-observer 
analysis. We propose two general designs for subsequent 
high-level studies:
1.  Patients could be recruited based on the initial mammogra-
phy or ultrasound BI-RADS® categorization. This setting 
would yield information about the ABVS as an adjunct 
to the conventional technique for these special groups of 
patients (eg, detecting previously occult cancers in women 
with a primary categorization of BI-RADS® 1 or 2; further 
describing a lesion in women with BI-RADS® 3 or 4; find-
ing additional lesions in women with BI-RADS® 5).
2.  The ABVS could also be used as the sole examination 
technique on a randomly assigned cohort of asymptomatic International Journal of Women’s Health
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women. The cohort could then be compared with age-
matched controls who are examined by the conventional 
techniques. This setting would yield data about the per-
formance of the ABVS as an ultrasound-based screening 
tool (eg, in the general population, in young women with 
dense breasts, in high-risk populations, and for detecting 
small lesions, for example).
Summary
As there is a lack of definite data, the ABVS should be used 
only within approved study protocols. So far, we do not recom-
mend integrating the ABVS into routine diagnostic procedures, 
neither as an adjunct nor as an alternative for HHUS.
In the future, the ABVS might demonstrate greater 
  usefulness with further improvements in technology and when 
the distinct diagnostic criteria have become standardized. 
  Currently, whether or not there will be an improvement in 
cancer detection or a reduction in unnecessary biopsies when 
using the ABVS as a diagnostic modality, remains unclear.
Appropriate clinical indications for this examination need 
to be developed and this method must undergo standardized 
imaging methodology evaluation and validation studies. 
Therefore, currently, the ABVS should remain a topic of future 
discussion and research within the proposed study designs.
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